JPS62138500A - Production of polypeptide - Google Patents

Production of polypeptide

Info

Publication number
JPS62138500A
JPS62138500A JP60279682A JP27968285A JPS62138500A JP S62138500 A JPS62138500 A JP S62138500A JP 60279682 A JP60279682 A JP 60279682A JP 27968285 A JP27968285 A JP 27968285A JP S62138500 A JPS62138500 A JP S62138500A
Authority
JP
Japan
Prior art keywords
compound
leu
water
peptide fragment
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP60279682A
Other languages
Japanese (ja)
Inventor
Keiichi Ono
圭一 小野
Hiroyuki Kai
甲斐 啓幸
Yoshiaki Takebayashi
竹林 淑明
Akihiko Sano
明彦 佐野
Kazuyuki Suwa
諏訪 和志
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Pharmaceuticals Co Ltd
Original Assignee
Sumitomo Pharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Pharmaceuticals Co Ltd filed Critical Sumitomo Pharmaceuticals Co Ltd
Priority to JP60279682A priority Critical patent/JPS62138500A/en
Priority to EP86102737A priority patent/EP0193910A3/en
Priority to KR1019860001580A priority patent/KR920006564B1/en
Publication of JPS62138500A publication Critical patent/JPS62138500A/en
Priority to US07/119,279 priority patent/US4774319A/en
Pending legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

PURPOSE:To efficiently obtain the titled compound of growth hormone-releasing factor short-chain peptide used for such as a remedy for microsomia, by reacting a condensate of specific peptide fragments having a protecting group with a specific peptide fragment having a protecting group successively, followed by deprotection. CONSTITUTION:A peptide fragment having a protecting group expressed by formula I is condensed with a peptide fragment having a protecting group expressed by formula II to obtain a condensate, which is then condensed with a peptide fragment having a protecting group expressed by formula III, further condensed with peptide fragments having a protecting group expressed by formulae IV and V successively and subjected to deprotection to obtain the aimed polypeptide expressed by formula VI. The condensation of these peptide fragments is preferably carried out by using a carbodiimide based condensing agent, additive, etc.

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は次のアミノ酸配列を有するポリペプチド(VI
)の製法に関する。
Detailed Description of the Invention [Industrial Field of Application] The present invention provides a polypeptide (VI
).

H−Tyr−A la−Asp−A Ia−T Ie−
Phe−Thr−Asn−Ser−Tyr−Arg−L
ys−Val−Leu−Gly−Gln−Leu−Se
r −Asp −I Ie−Met −Ser −Ar
g −N H2(VI) 本ペプチドは成長ホルモン放出因子( growth hormone releasingf
actor ; G RF)の短鎖ペプチド誘導体であ
る。
H-Tyr-A la-Asp-A Ia-T Ie-
Phe-Thr-Asn-Ser-Tyr-Arg-L
ys-Val-Leu-Gly-Gln-Leu-Se
r -Asp -I Ie-Met -Ser -Ar
g -NH2(VI) This peptide is a growth hormone releasing factor (growth hormone releasing factor).
is a short-chain peptide derivative of GRF).

本ペプチドはGRFと同様強い成長ホルモン分泌促進作
用を有することから、小人症等種々の成長ホルモン欠乏
症に有効であるばかりか、抗潰瘍剤、創傷の治療剤等と
しての利用も考えられ、医薬品として極めて有用である
Like GRF, this peptide has a strong growth hormone secretion promoting effect, so it is not only effective for various growth hormone deficiency diseases such as dwarfism, but also can be used as an anti-ulcer agent, wound treatment agent, etc. It is extremely useful as a

さらに本ペプチドはヒトばかりでなく種々の動物に対し
ても成長ホルモン分泌促進作用を有することより商用動
物における成長速度および成長度合の増大、ミルク収率
の増加に有用である。
Furthermore, this peptide has a growth hormone secretion promoting effect not only in humans but also in various animals, and is therefore useful for increasing the growth rate and degree of growth and milk yield in commercial animals.

〔従来技術と発明が解決しようきする間頴点〕本ペプチ
ドの製法については既に固相法を用いる方法が知られて
いる( N ature、 300゜276、 (19
82) )。
[The problem that can be solved by the prior art and the invention] A solid-phase method is already known for producing the present peptide (Nature, 300°276, (19)
82) ).

また、液相法ではステップワイズ法とフラグメント縮合
法がある。フラグメント縮合法は生成物の精製の容易さ
、ペプチド純度等の点ですぐれた方法であるが、フラグ
メント縮合を行う場合、多くのフラグメントの組み合せ
の中からどのようにフラグメントを選択するかが重要な
課題となる。
Furthermore, the liquid phase method includes a stepwise method and a fragment condensation method. The fragment condensation method is an excellent method in terms of ease of product purification and peptide purity, but when performing fragment condensation, it is important to select a fragment from among many combinations of fragments. It becomes a challenge.

〔発明の構成〕[Structure of the invention]

本発明者らはフラグメント縮合法として、ペプチドフラ
グメントの溶媒に対する溶解性、ペプチドフラグメント
の反応性および生成物の精製法等について種々検討し、
下記の5個のペプチドフラグメント(I)〜(V)をペ
プチドフラグメント(I)から順次縮合させ、ポリペプ
チド(VI)を製造するのが効率的であることを見出し
、本発明を完成したのである。
The present inventors conducted various studies on the solubility of peptide fragments in solvents, reactivity of peptide fragments, purification methods of products, etc. as a fragment condensation method.
They discovered that it is efficient to produce polypeptide (VI) by sequentially condensing the following five peptide fragments (I) to (V) starting from peptide fragment (I), and completed the present invention. .

ペプチドフラグメント(I) Leu−Gln−Asp −I Ie −Met −S
er −Arg  Nl+2 ペプチドフラグメント(n) Gln−Leu−Ser−Ala−Arg−Lys −
Leu ペプチドフラグメント(I) Arg−Lys−Val−Leu−Glyペプチドフラ
グメント(rV) I le −Phe −Thr−Asn−5er−Ty
rペプチドフラグメント(V) Tyr −A la−Asp −A Ia(式中グリシ
ンを除くすべてのアミノ酸はL体を表わす) 即ち本発明は保護基を有するペプチドフラグメント(I
)と保護基を有するペプチドフラグメン)(U)を縮合
させ縮合物を得、次いでこの縮合物と保護基を有するペ
プチドフラグメント(I)と縮合させる。以下順次保護
基を有するペプチドフラグメント(IV)、(V)を縮
合させた後、脱保護することを特徴とする高純度ポリペ
プチド(VI)の製法である。
Peptide fragment (I) Leu-Gln-Asp -I Ie -Met -S
er -Arg Nl+2 Peptide fragment (n) Gln-Leu-Ser-Ala-Arg-Lys -
Leu peptide fragment (I) Arg-Lys-Val-Leu-Gly peptide fragment (rV) I le -Phe -Thr-Asn-5er-Ty
r peptide fragment (V) Tyr -A la -Asp -A Ia (in the formula, all amino acids except glycine represent the L-configuration) That is, the present invention provides a peptide fragment (I
) and a peptide fragment (U) having a protecting group are condensed to obtain a condensate, and then this condensate is condensed with a peptide fragment (I) having a protecting group. The following is a method for producing a highly pure polypeptide (VI), which is characterized in that peptide fragments (IV) and (V) having protecting groups are sequentially condensed and then deprotected.

本発明では、縮合方法としては、例えばアジド法、酸化
還元法、ジフェニルホスホリルアジド法、カルボジイミ
ド型縮合剤士添加物法等、ラセミ化を起こさない方法が
用いられるが、本発明者等はカルボジイミド型縮合剤+
添加物法が以下の利点を持ち工業的製造法として最も有
利であることを発見した。
In the present invention, as a condensation method, a method that does not cause racemization is used, such as an azide method, a redox method, a diphenylphosphoryl azide method, a carbodiimide type condensation additive method, etc. Condensing agent +
It has been discovered that the additive method has the following advantages and is the most advantageous as an industrial manufacturing method.

(1)操作が非常に簡便である。(原料と試葵を溶媒に
加え、攪拌するだけで良い。) (2)冷却の必要が無い。
(1) Operation is very simple. (Just add the raw materials and sample hollyhock to the solvent and stir.) (2) No need for cooling.

(3)副反応が、はとんど無く簡単な後処理操作で高純
度の目的物を得ることができる。
(3) There are almost no side reactions, and a highly pure target product can be obtained with simple post-treatment operations.

カルボジイミド型縮合剤十添加物法の場合はフラグメン
トの縮合反応は例えば次の如く行われる。すなわち遊離
カルボキシル基及び適当な保護基により保護された反応
性基を有するペプチドと遊離アミノ基及び適当な保護基
により保護された反応性基を有するペプチドを適当な溶
媒に溶解した後、カルボジイミド型縮合剤と添加物を加
え攪拌する。その際に要すれば適当な塩基を加えて反応
混合物を弱アルカリ性に保っても良い。
In the case of the carbodiimide type condensing agent/additive method, the condensation reaction of fragments is carried out, for example, as follows. That is, a peptide having a free carboxyl group and a reactive group protected by an appropriate protecting group and a peptide having a free amino group and a reactive group protected by an appropriate protecting group are dissolved in an appropriate solvent, and then subjected to carbodiimide-type condensation. Add the agent and additives and stir. At that time, if necessary, a suitable base may be added to keep the reaction mixture slightly alkaline.

溶媒としては種々のものが使用でき例えばジメチルスル
ホキシド、ジメチルホルムアミド、ヘキサメチルホスホ
ロアミド、ジオキサン、テトラヒドロフラン、N−メチ
ルピロリドンまたはそれらの混合物等を挙げることがで
きる。
Various solvents can be used, including dimethyl sulfoxide, dimethylformamide, hexamethylphosphoramide, dioxane, tetrahydrofuran, N-methylpyrrolidone, and mixtures thereof.

カルボジイミド型縮合剤としては例えばジシクロへキシ
ルカルボジイミド(DCC)、1−エチル−3−(3−
ジメチルアミノプロピル)−カルボジイミド、1−エチ
ル−3−(3−ジメチルアミノプロピル)−カルボジイ
ミド塩酸塩等を用いることができる。
Examples of carbodiimide-type condensing agents include dicyclohexylcarbodiimide (DCC), 1-ethyl-3-(3-
Dimethylaminopropyl)-carbodiimide, 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide hydrochloride, etc. can be used.

カルボジイミド型縮合剤士添加物法における添加物とし
ては例えばN−ヒドロキシコノ飄り酸イミド、1−ヒド
ロキシベンゾトリアゾール、N−ヒドロキシ−5−ノル
ボルネン−2,3−ジカルボキシイミド等を用いること
ができる。また縮合の反応は通常−20℃〜40℃程度
の反応温度で進行させて支障は無い。
As additives in the carbodiimide type condensation additive method, for example, N-hydroxyconocarboxylic acid imide, 1-hydroxybenzotriazole, N-hydroxy-5-norbornene-2,3-dicarboximide, etc. can be used. . Further, the condensation reaction can normally proceed at a reaction temperature of about -20°C to 40°C without any problem.

本方法における保護基の除去手段としては通常ペプチド
合成分野で使用される方法、例えばトリフルオロ酢酸、
メタンスルホン酸、p−)ルエンスルホンFf12、キ
酸、臭化水素−酢酸、トリフルオロメタンスルホン酸、
フッ化水素等による酸分解、パラジウム黒、パラジウム
炭素、白金などを触媒とする水素添加や液体アンモニア
中でのナトリウムを用いる還元的方法、亜鉛−酢酸法等
が挙げられる。
As a means for removing the protecting group in this method, methods commonly used in the field of peptide synthesis, such as trifluoroacetic acid,
Methanesulfonic acid, p-)luenesulfone Ff12, phosphoric acid, hydrogen bromide-acetic acid, trifluoromethanesulfonic acid,
Examples include acid decomposition using hydrogen fluoride, hydrogenation using palladium black, palladium carbon, platinum, etc. as a catalyst, a reductive method using sodium in liquid ammonia, and a zinc-acetic acid method.

酸分解においては水、アニソール、フェノール、チオフ
ェノール、チオアニソール、クレゾール、メチルエチル
スルフィド等のカチオン捕捉剤を添加すると好都合なこ
とがある。
In acid decomposition it may be advantageous to add water, cation scavengers such as anisole, phenol, thiophenol, thioanisole, cresol, methyl ethyl sulfide.

還元や酸分解による保護基の除去反応は通常−40℃〜
40℃程度の反応温度で進行させて支障はない。
Removal reactions of protecting groups by reduction or acid decomposition are usually carried out at -40℃~
There is no problem in proceeding at a reaction temperature of about 40°C.

本発明において用いられる保護基としては、アミノ酸の
アミノ基には例えばトシル基、ベンジルオキシカルボニ
ル基、第3級ブチルオキシカルボニル基、トリチル基、
p−メトキシベンジルオキシカルボニル基、ホルミル基
、トリフルオロアセチル基、0−ニトロフェニルスルフ
ェニル基、3−ニトロ−2−ピリジンスルフェニル基等
、またアミノ酸のカルボキシル基の保護には例えばメチ
ルエステル、エチルエステル、イソプロピルエステル、
第3級ブチルエステル、シクロペンチルエステル、シク
ロヘキシルエステル等の低級アルキルエステルおよびベ
ンジルエステル、p−メトキシベンンルエステル、p−
二トロペンジルエステル、フェナシルエステル等、ペプ
チド合成分野で通常使用されている保護基をあげること
ができる。またセリン、スレオニン、チロシンなどの水
酸基の保護は必ずしも必須ではないが、要すれば例えば
アセチル基、ベンジル基、2.6−ジクロロベンジル基
、ベンジルオキシカルボニル基、第3級ブチル基等、通
常の水酸基保護基によって保護することができる。アル
ギニンのグアニド基の保護には、例えばニトロ基、トシ
ル基、ベンジルオキシカルボニル基、アダマンチルオキ
シカルボニル基、イソボルニルオキシカルボニル基、メ
シチレン−2−スルホニル基等を用いることができる。
Protecting groups used in the present invention include, for example, tosyl group, benzyloxycarbonyl group, tertiary butyloxycarbonyl group, trityl group,
p-methoxybenzyloxycarbonyl group, formyl group, trifluoroacetyl group, 0-nitrophenylsulfenyl group, 3-nitro-2-pyridinesulfenyl group, etc. Also, for protecting the carboxyl group of amino acids, for example, methyl ester, ethyl ester, isopropyl ester,
Lower alkyl esters and benzyl esters such as tertiary butyl ester, cyclopentyl ester, cyclohexyl ester, p-methoxybenyl ester, p-
Examples include protecting groups commonly used in the field of peptide synthesis, such as ditropendyl ester and phenacyl ester. In addition, protection of hydroxyl groups such as serine, threonine, and tyrosine is not necessarily essential, but if necessary, protection of hydroxyl groups such as acetyl group, benzyl group, 2,6-dichlorobenzyl group, benzyloxycarbonyl group, tertiary butyl group, etc. It can be protected by a hydroxyl protecting group. To protect the guanido group of arginine, for example, a nitro group, tosyl group, benzyloxycarbonyl group, adamantyloxycarbonyl group, isobornyloxycarbonyl group, mesitylene-2-sulfonyl group, etc. can be used.

メチオニンは要すればスルホキシドとして保護すること
も可能である。
Methionine can also be protected as a sulfoxide if desired.

本発明によって製造されるポリペプチド(VI)の精製
は例えばイオン交換樹脂、分配クロマトグラフィー、ゲ
ルクロマトグラフィー、逆相型液体クロマトグラフィー
等、ペプチド化学の分野で通常用いられる方法を単独に
または組み合わせて用いることによって行うことができ
る。
The polypeptide (VI) produced by the present invention can be purified using methods commonly used in the field of peptide chemistry, such as ion exchange resin, partition chromatography, gel chromatography, and reversed-phase liquid chromatography, either singly or in combination. This can be done by using

上記のごとく製造された高純度ポリペプチド(VI)は
、ラットを用いたインビボ(invivo>試験および
ラットの下垂体細胞を用いたインビトロ(in vit
ro)試験において強い成長ホルモン放出作用を示した
The highly purified polypeptide (VI) produced as described above was tested in vivo using rats and in vitro using rat pituitary cells.
ro) showed a strong growth hormone releasing effect in the test.

なお、本発明におけるペプチドフラグメント(I)〜(
V)の合成については通常のペプチド合成法に従って行
うことができる。
In addition, peptide fragments (I) to (
The synthesis of V) can be carried out according to conventional peptide synthesis methods.

該公知方法としては例えばM 、 B odansky
及びM 、 A 、 Ondetti著ペブチドシンセ
シス(Peptide 5ynthesis) 、  
Interscience社 New York、 1
966年; F、 M、 F inn及び’f、 、 
l(Ofmann著、ザ プロテインズ(The Pr
oteins) 、’12巻、H、N eurath、
 R,L、 Hil1編集、Δcademic Pre
ssInc、  、 New York 、 1976
年;泉屋信夫他著、ペプチド合成、丸蓋側、1975年
;日本生化学全編、生化学実験講座、第−巻、タンパク
質の化学■、第■部、矢島冶明著、ペプチド合成、19
77年などに記載されている方法等が挙げられる。
The known method includes, for example, M. Bodansky.
and Peptide Synthesis by M.A. Ondetti,
Interscience New York, 1
966; F, M, F inn and 'f, ,
l (Ofmann, The Proteins)
oteins), Volume 12, H, Neuroth,
Edited by R, L, Hil1, Δcademic Pre
ssInc, New York, 1976
Year: Nobuo Izumiya et al., Peptide Synthesis, round lid side, 1975; Complete Japanese Biochemistry, Biochemistry Experiment Course, Volume -, Chemistry of Proteins ■, Part ■, Yoshiaki Yajima, Peptide Synthesis, 19
Examples include the method described in 1977.

〔参考例及び実施例〕[Reference examples and working examples]

以下に参考例及び実施例をあげ、本発明を説明するが、
これはあくまでも−例であって何ら本発明の技術的範囲
を制限するものではない。
The present invention will be explained below with reference examples and examples.
This is just an example and does not limit the technical scope of the present invention in any way.

なお、用いたアミノ酸はグリシンを除き、いずれもL型
のものであり、アミノ酸の略号は一般の用法に従い英字
名のはじめの3字で表わしている(例外としてAsn−
アスパラギン、GIn=グルタミン)。その他の略号は
次に示すとおりである。
All of the amino acids used, except for glycine, are L-type, and amino acid abbreviations are represented by the first three letters of their names in accordance with general usage (with the exception of Asn-
asparagine, GIn=glutamine). Other abbreviations are as follows.

PMZ:p−メトキシベンジルオキシカルボニル、Bo
c:t−ブチルオキシカルボニル、Mts:メシチレン
ー2−スルフォニル、ONp:p−ニトロフェノールエ
ステル、Bzl:ベンジル、Cl2− Bzl : 2
 、6−ジクロロベンジル、Opac :7エナシルエ
ステル、0Bzl:ベンジルエステル、Z:ベンジルオ
キシカルボニル、TFA : l−リフルオロ酢酸、 
 TosOH:p−トルエンスルホン酸、HOBt  
:1−ヒドロキシベンゾトリアゾール、 5BCF:クロル蟻酸第ニブチル、DCHAニジシクロ
ヘキシルアミン、NMM:N−メチルモルホリン、Et
iN : )リエチルアミン、CHA ニジクロヘキシ
ルアミン、DC’Cニジシクロへキシルカルボジイミド
、wsc:t−エチル−3−(3−ジメチルアミノプロ
ピル)−カルボジイミド、MeOH:メタノール、TH
F :テトラヒドロフラン、EtOH:エチルアルコー
ル、DMFニジメチルホルムアミド、DMS○ニジメチ
ルスルフオキシド、Ac0NH4:酢酸アンモニウム。
PMZ: p-methoxybenzyloxycarbonyl, Bo
c: t-butyloxycarbonyl, Mts: mesitylene-2-sulfonyl, ONp: p-nitrophenol ester, Bzl: benzyl, Cl2- Bzl: 2
, 6-dichlorobenzyl, Opac: 7 enacyl ester, 0Bzl: benzyl ester, Z: benzyloxycarbonyl, TFA: l-lifluoroacetic acid,
TosOH: p-toluenesulfonic acid, HOBt
: 1-Hydroxybenzotriazole, 5BCF: Nibutyl chloroformate, DCHA dicyclohexylamine, NMM: N-methylmorpholine, Et
iN: ) ethylamine, CHA dichlorohexylamine, DC'C dicyclohexylcarbodiimide, wsc: t-ethyl-3-(3-dimethylaminopropyl)-carbodiimide, MeOH: methanol, TH
F: Tetrahydrofuran, EtOH: Ethyl alcohol, DMF Nidimethylformamide, DMS○ Nidimethylsulfoxide, Ac0NH4: Ammonium acetate.

HO5u:N−ヒドロキシサクシンイミド参前例I  
Boc−Gln−Leu−Ser(Bzl)−Ala−
Arg(Mts)−Lys(Zl−Leu−OH(化合
物8)の製造 (1)  Boc−Lys(Z) −Leu−Opac
  (化合物1)の製造 Boc −Lys (Z ) −0821,7gを酢酸
エチル100m1に溶解しNMM5.76gを加える。
HO5u: N-hydroxysuccinimide example I
Boc-Gln-Leu-Ser(Bzl)-Ala-
Production of Arg(Mts)-Lys(Zl-Leu-OH (compound 8) (1) Boc-Lys(Z)-Leu-Opac
Preparation of (Compound 1) 7 g of Boc-Lys (Z)-0821 is dissolved in 100 ml of ethyl acetate, and 5.76 g of NMM is added.

−10℃で冷却下5BCF 7.81gを15分間滴下
する。次いで15分旧拌後TosOt(・H−Leu−
OPac 20.OgをDMF50mlに溶解し一10
℃に冷却したものを加える。次に4.80gのNMMを
DMF5mlに溶解し1時間滴下する。−10℃で3時
間攪拌後自然昇湿させながら3時間皿押する。酢酸エチ
ル300m lを加え、次いで5%クエン酸水、5%炭
酸水素ナトリウム水、飽和食塩水の順に洗浄し硫酸マグ
ネシウム上で乾怪後溶媒を留去する。残渣を携取し石油
エーテルで洗浄して化合物1を得る。
While cooling at −10° C., 7.81 g of 5BCF is added dropwise for 15 minutes. Then, after stirring for 15 minutes, TosOt(・H-Leu-
OPac 20. Dissolve Og in 50ml of DMF and
Add cooled to ℃. Next, 4.80 g of NMM was dissolved in 5 ml of DMF and added dropwise for 1 hour. After stirring at -10°C for 3 hours, the mixture was pressed in a dish for 3 hours while allowing natural humidity to rise. Add 300 ml of ethyl acetate, then wash with 5% citric acid solution, 5% sodium bicarbonate solution, and saturated saline in this order, dry over magnesium sulfate, and then evaporate the solvent. The residue is taken and washed with petroleum ether to obtain compound 1.

収量 29.4 g (1,00%) 融点 61〜70℃ 〔α:]、−39.9° (C= 1 、MeOH)(
2)  TosOHl(−Lys(Z)−Leu−OP
ac(化合物2)の製造 化合物1 27.0gをアセトニトリル300m1に溶
解する。p−トルエンスルホン酸−水和物16.8gを
加え室温で3時間攪拌する。析出した結晶を濾取する。
Yield 29.4 g (1,00%) Melting point 61-70°C [α:], -39.9° (C=1, MeOH) (
2) TosOHl(-Lys(Z)-Leu-OP
Preparation of ac (Compound 2) 27.0 g of Compound 1 is dissolved in 300 ml of acetonitrile. Add 16.8 g of p-toluenesulfonic acid hydrate and stir at room temperature for 3 hours. The precipitated crystals are collected by filtration.

濾液の溶媒を留去し、残渣を濾取し、石油エーテルで洗
浄する。濾取した両方の結晶を合わせて乾退し、化合物
2を得る。
The filtrate is evaporated and the residue is filtered and washed with petroleum ether. Both crystals collected by filtration are combined and dried to obtain Compound 2.

収量 28.7g (94,9%) 融点 139〜143℃ CtX〕、−16,3°(C= 1 、MeOH)(3
)  PMZ−Arg(Mts)−Lys(Z)−Le
u−OPac(化合物3)の製造 PMZ−Arg(Mts) −0H−CHA 37.8
gを酢酸エチル500m l及び5%クエン酸氷水20
01に懸濁する。全て溶解した後層を分離させ、有機層
を硫酸マグネシウム上で乾煙し溶媒を留去する。残渣を
THFloomlに溶解しNMM 5.69gを加える
。−10℃で冷却下5BCF 8.35gを15分間滴
下する。
Yield 28.7g (94.9%) Melting point 139-143°C CtX], -16.3° (C=1, MeOH) (3
) PMZ-Arg(Mts)-Lys(Z)-Le
Preparation of u-OPac (Compound 3) PMZ-Arg(Mts) -0H-CHA 37.8
g to 500ml of ethyl acetate and 20ml of 5% citric acid in ice water.
01. After everything is dissolved, the layers are separated, the organic layer is dried over magnesium sulfate, and the solvent is distilled off. Dissolve the residue in THFlooml and add 5.69 g of NMM. While cooling at −10° C., 8.35 g of 5BCF is added dropwise for 15 minutes.

次いで化合物2 32.1g及びN M M 、174
gをDMF20ml及びTHF30mlの混合物に溶解
し冷却下15分間滴下する。自然昇温させながら3時間
攪拌する。酢酸エチル500m1及び水200m1を加
え、層を分離する。有機層を5%クエン酸水、5%炭酸
水素ナトリウム水、飽和食塩水の順に洗浄する。硫酸マ
グネシウム上で乾爆し溶媒を留去する。残渣を濾取し石
油エーテルで洗浄し、化合物3を得る。
Then 32.1 g of compound 2 and N M M , 174
g was dissolved in a mixture of 20 ml of DMF and 30 ml of THF and added dropwise for 15 minutes under cooling. Stir for 3 hours while allowing the temperature to rise naturally. 500 ml of ethyl acetate and 200 ml of water are added and the layers are separated. The organic layer is washed sequentially with 5% citric acid water, 5% sodium bicarbonate water, and saturated saline. Dry blast over magnesium sulfate and evaporate the solvent. The residue is filtered and washed with petroleum ether to obtain compound 3.

収量 46.1g (96,9%) 融点 106〜107℃ 〔α)、−24,3°(C= 1 、MeOH)(4)
  Boa−Ala−Arg(Mts)−Lys(Z)
−Leu−OPac(化合物4)の製造 化合物3 19.7gを塩化メチレン20m1及びアニ
ソール5mlに急濁する。氷冷下TFA20m lを加
え1時間攪拌後溶媒を留去する。エーテルを加え粉末と
した後濾取乾怪し、脱PMZ化物を得る。次にこの粉末
をDMF50mlに溶解しNMM2.35gで中和する
Yield 46.1g (96.9%) Melting point 106-107°C [α), -24.3° (C=1, MeOH) (4)
Boa-Ala-Arg(Mts)-Lys(Z)
Preparation of -Leu-OPac (Compound 4) 19.7 g of Compound 3 is suspended in 20 ml of methylene chloride and 5 ml of anisole. Add 20 ml of TFA under ice cooling, stir for 1 hour, and then evaporate the solvent. After adding ether to the powder, it was filtered and dried to obtain a PMZ-free product. Next, this powder was dissolved in 50 ml of DMF and neutralized with 2.35 g of NMM.

一方、Boc−Ala−OH4,76gを酢酸エチル1
00m1に溶解しNMM2.35gを加える。
On the other hand, 4.76 g of Boc-Ala-OH was added to 1 ml of ethyl acetate.
00ml and add 2.35g of NMM.

−10℃で冷却下5BCF3.19gを15分間滴下す
る。脱PMZ化物溶液を冷却下30分間滴下する。自然
昇温させながら3時間攪拌する。
While cooling at −10° C., 3.19 g of 5BCF is added dropwise for 15 minutes. The PMZ-removed solution is added dropwise for 30 minutes under cooling. Stir for 3 hours while allowing the temperature to rise naturally.

酢酸エチル200m l及び水100m1を加え層を分
離する。有機層を5%クエン酸水、5%炭酸水素ナトリ
ウム水、飽和食塩水の順に洗浄する。硫酸マグネシウム
上で乾煙し溶媒を留去する。残渣を濾取し、石油エーテ
ルで洗浄して化合物4を得る。
Add 200 ml of ethyl acetate and 100 ml of water and separate the layers. The organic layer is washed sequentially with 5% citric acid water, 5% sodium bicarbonate water, and saturated saline. Dry smoke over magnesium sulfate and evaporate the solvent. The residue is filtered and washed with petroleum ether to obtain compound 4.

収量 17.2g (86,9%) 融点 100〜104℃ [α]。−39,4°(C=1.MeOH)(5)  
Boa−3et(Bzl)−Ala−Arg(Mts)
−Lys(Z)−Lau−OPac(化合物5)の製造 化合物4 8.31gをアセトニトリル25m1に溶解
しp−)ルエンスルホン酸−水和物15.5gを加え室
温で2時間攪拌する。−10℃に冷却下NMM8.22
gで中和し脱Boc化物溶液を得る。
Yield 17.2g (86.9%) Melting point 100-104°C [α]. -39,4° (C=1.MeOH) (5)
Boa-3et(Bzl)-Ala-Arg(Mts)
Production of -Lys(Z)-Lau-OPac (Compound 5) 8.31 g of Compound 4 was dissolved in 25 ml of acetonitrile, 15.5 g of p-)luenesulfonic acid hydrate was added, and the mixture was stirred at room temperature for 2 hours. NMM8.22 under cooling to -10℃
Neutralize with g to obtain a de-Boc solution.

一方、Boc −Set (Bzl) −0H2,88
gをTHFlomlに溶解しNMMo、99gを加える
。−10℃で冷却下5BCF 1.34gを加え15分
間攪拌する。先の脱Boc化物溶液を15分間滴下し自
然昇温させながら3時間攪拌する。
On the other hand, Boc -Set (Bzl) -0H2,88
Dissolve g in THFloml and add 99 g of NMMo. While cooling at -10°C, add 1.34 g of 5BCF and stir for 15 minutes. The above Boc-removed solution was added dropwise for 15 minutes, and the mixture was stirred for 3 hours while allowing the temperature to rise naturally.

酢酸エチル300m1及び水100m1を加え層を分離
する。有機層を5%クエン酸水、5%炭酸水素すl−U
ラム水、水の順に洗浄する。溶媒を留去後残渣を濾取し
、エーテルで洗浄して化合物5を得る。
Add 300 ml of ethyl acetate and 100 ml of water and separate the layers. The organic layer was mixed with 5% citric acid water and 5% hydrogen carbonate l-U.
Rinse with rum water and then water. After evaporating the solvent, the residue is collected by filtration and washed with ether to obtain Compound 5.

収量 10.5g (89,7%) 融点 120〜123℃ CCx〕n  2R,7(C= 1 、 MeOH)(
6)  Boc−Leu−Ser(Bzl> −Ala
−Arg(Mts)−Lys(Z)−Leu−OPac
(化合物6)の製造 化合物5 7.5gをアセトニトリル50m1に懸局し
、p−)ルエンスルホン酸−水和物11.8gを加え室
温で1時間攪拌する。−10℃に冷却下NMM6.32
gで中和し脱Boc化物溶液を得る。一方Boc −L
eu −OH・H201、87gを酢酸エチル5mlに
溶解し硫酸マグネシウム上で乾慢する。NMM O,7
5gを加え一10℃に冷却下5BCF 1.03gを加
え15分間攪拌する。先の脱Boc化物溶液を冷却下1
5分間滴下し自然昇温させながら3時間攪拌する。酢酸
エチル300m l及び水100+n+を加え層を分離
する。有機層を5%クエン酸水、5%炭酸水素す) I
Jウム水、水の順に洗浄する。
Yield 10.5g (89.7%) Melting point 120-123℃ CCx]n 2R,7 (C=1, MeOH) (
6) Boc-Leu-Ser(Bzl>-Ala
-Arg(Mts)-Lys(Z)-Leu-OPac
Preparation of (Compound 6) 7.5 g of Compound 5 was suspended in 50 ml of acetonitrile, 11.8 g of p-)luenesulfonic acid hydrate was added, and the mixture was stirred at room temperature for 1 hour. NMM6.32 under cooling to -10℃
Neutralize with g to obtain a de-Boc solution. On the other hand, Boc-L
87 g of eu -OH.H201 was dissolved in 5 ml of ethyl acetate and dried over magnesium sulfate. NMM O, 7
Add 5g of 5BCF, and while cooling to -10°C, add 1.03g of 5BCF and stir for 15 minutes. The previous de-Boc compound solution was cooled 1
Add dropwise for 5 minutes and stir for 3 hours while allowing the temperature to rise naturally. Add 300 ml of ethyl acetate and 100+n+ of water and separate the layers. The organic layer was dissolved in 5% citric acid water and 5% hydrogen carbonate) I
Wash with water and water in that order.

溶媒を留去し残渣を濾取、エーテルで洗浄して化合物6
を得る。
The solvent was distilled off, the residue was collected by filtration, and washed with ether to obtain compound 6.
get.

収量 6.98g (85,0%) 融点 164〜165℃ [(2) o−27,8°(C=1.MeOH)(7)
  Boc−Gln−Leu−Ser(Bzl) −A
la −Arg(Mts)−Lys(Z)−Leu−O
Pac(化合物?)の製造 化合物6 5.00gをアセトニトリル50m1に息層
し、p−トルエンスルホン酸−水和物7.24gを加え
1時間攪拌する。NMM3.84gを加えて中和した後
アセトニトリルを留去する。残渣をD M F 10m
1に溶解しBoc−Gln−ONp2.80gを加える
。NMMを加え弱アルカリ性(pH7〜8)に保ちなが
ら室温で16時間攪拌する。水200m1に反応混合物
を滴下する。析出した沈澱を濾取し粗結晶を得る。
Yield 6.98g (85.0%) Melting point 164-165℃ [(2) o-27.8° (C=1.MeOH) (7)
Boc-Gln-Leu-Ser(Bzl)-A
la -Arg(Mts)-Lys(Z)-Leu-O
Preparation of Pac (compound?) 5.00 g of Compound 6 was added to 50 ml of acetonitrile, 7.24 g of p-toluenesulfonic acid hydrate was added, and the mixture was stirred for 1 hour. After neutralizing by adding 3.84 g of NMM, acetonitrile is distilled off. D MF 10m of the residue
1 and add 2.80 g of Boc-Gln-ONp. Add NMM and stir at room temperature for 16 hours while keeping the mixture slightly alkaline (pH 7-8). The reaction mixture is added dropwise to 200 ml of water. The deposited precipitate is collected by filtration to obtain crude crystals.

粗結晶を酢酸二fk 200m1ニ9濁し50℃テ30
分間攪拌する。瀘取乾怪して化合物7を得る。
The crude crystals were clouded with 200ml of acetic acid and heated to 50°C for 30 minutes.
Stir for a minute. Obtain Compound 7 by removing the filter.

収量 4.57g (83,2%) 融点 204〜208℃ [α] 、−20,1°(C=1.DMSO)(8) 
 Boa−Gln−Leu−5er(Bzl)−Ala
 −Arg(Mts) −Lys(Z) −Leu−O
H(化合物8)の製造 化合物7 3.50gを酢酸50m1に溶解する。
Yield 4.57g (83.2%) Melting point 204-208℃ [α], -20.1° (C=1.DMSO) (8)
Boa-Gln-Leu-5er (Bzl)-Ala
-Arg(Mts) -Lys(Z) -Leu-O
Preparation of H (Compound 8) 3.50 g of Compound 7 is dissolved in 50 ml of acetic acid.

亜鉛粉末3.0gを加え室温で2時間攪拌する。Add 3.0 g of zinc powder and stir at room temperature for 2 hours.

不溶物を濾別した後溶媒を留去する。残渣を水洗し濾取
乾煙して化合物8を得る。
After filtering off insoluble matter, the solvent is distilled off. The residue is washed with water, filtered and smoked to obtain Compound 8.

収量 3.07g (95,5%) 融点 192〜194℃ 〔α〕、−14,3°(C=1.DMSO)参考例2 
 PMZ−Arg(Mts)−Lys(Z)−Val−
Leu−Gly−OH(化合物13)の製造 (1)  Boc−Leu−Gay−OPac(化合物
9)の製造 Boc−Leu−OH−HzO16,7gを酢酸エチル
400m1と飽和食塩水200m lを加え分岐する。
Yield 3.07g (95.5%) Melting point 192-194°C [α], -14.3° (C=1.DMSO) Reference Example 2
PMZ-Arg(Mts)-Lys(Z)-Val-
Production of Leu-Gly-OH (Compound 13) (1) Production of Boc-Leu-Gay-OPac (Compound 9) 16.7 g of Boc-Leu-OH-HzO was added with 400 ml of ethyl acetate and 200 ml of saturated brine and branched. .

上層を飽和食塩水200m lで洗浄し、硫酸マグネシ
ウムにて乾爆後溶媒を留去し、得られた残渣をDMFl
oomlに溶解しTosOH・H−Gly−OPac 
23.3g、 HOBt 9.Ogを加え、−15℃に
冷却しWSClo、4gを滴下する。3時間後、室温に
戻し24時間攪拌する。
The upper layer was washed with 200 ml of saturated saline, and after drying with magnesium sulfate, the solvent was distilled off, and the resulting residue was diluted with DMF1.
Dissolve in ooml TosOH・H-Gly-OPac
23.3g, HOBt 9. Add Og, cool to -15°C, and dropwise add 4 g of WSClo. After 3 hours, the mixture was returned to room temperature and stirred for 24 hours.

反応液にトルエン500m lと水300m1を加え分
液する。上層を水、5%炭酸水素すI−IJウム水、5
%クエン酸水、飽和食塩水の順に洗浄し硫酸マグネシウ
ムにて乾繰後、溶媒を留去し得られた残渣にエーテルを
100m1加え、攪拌下ヘキサン400m1を加え結晶
化する。結晶を誘取、ヘキサン洗浄し乾爆して化合物9
を得る。
Add 500 ml of toluene and 300 ml of water to the reaction solution and separate the liquid. The upper layer is water, 5% hydrogen carbonate water, 5
% citric acid solution and saturated saline solution, and dried over magnesium sulfate, the solvent was distilled off, and 100 ml of ether was added to the resulting residue, followed by crystallization by adding 400 ml of hexane while stirring. Collect the crystals, wash them with hexane, and dry-blast them to obtain compound 9.
get.

収量 24.2g (93,5%) 融点 108〜110℃ Ccr〕、−29゜5° (C= 1 、MeOH)(
2)  Boc −Val−4eu −G Iy −O
Pac (化合物10)の製造 化合物9 18.9gをアセトニトリル190m1に溶
解し、TosOH・H−035,4gを加え室温で1時
間半攪拌後、溶媒を留去し、得られた残渣をTHF90
mlに溶解し、水冷下EtJ19、6mlで中和する。
Yield 24.2g (93.5%) Melting point 108-110℃ Ccr], -29°5° (C=1, MeOH) (
2) Boc -Val-4eu -G Iy -O
Preparation of Pac (Compound 10) 18.9 g of Compound 9 was dissolved in 190 ml of acetonitrile, 4 g of TosOH.H-035 was added, and after stirring at room temperature for 1.5 hours, the solvent was distilled off, and the resulting residue was dissolved in THF90.
ml and neutralized with 6 ml of EtJ19 while cooling with water.

この溶液にHOBt’6.9g、 Boc−Val−O
H11,1gを加えW S C8,0gを滴下する。2
時間後、室温に戻し24時間攪拌する。反応液に酢酸エ
チル500m lと水300m lを加え分液する。上
層を水、5%炭酸水素ナトリウム水、5%クエン酸水、
飽和食塩水の順に洗浄し、溶媒を留去し得られた残渣に
石油エーテル500m lを加え結晶化する。結晶を濾
取、石油エーテル洗浄し乾燥して化合物10を得る。
In this solution, 6.9 g of HOBt', Boc-Val-O
Add 11.1 g of H and dropwise add 8.0 g of W SC. 2
After that time, the mixture was returned to room temperature and stirred for 24 hours. Add 500 ml of ethyl acetate and 300 ml of water to the reaction solution and separate the layers. The upper layer is water, 5% sodium bicarbonate water, 5% citric acid water,
The mixture is washed with saturated brine, the solvent is distilled off, and 500 ml of petroleum ether is added to the resulting residue for crystallization. The crystals are collected by filtration, washed with petroleum ether, and dried to obtain Compound 10.

収量 22.0g <93.6%) 融点 146〜147℃ CCr〕、−54,8°(C= 1 、MeOH)(3
)  Boc−Lys(Z) −Val−Leu−Gl
y −0Pac(化合物11)の製造 化合物10 21.5gをT F A 66.5mlに
溶解し、室温で40分攪拌した後、T HF 140m
1を加え水冷下E ta N 113.3mlで中和す
る。この溶液にHOBt 6JgSBoc−Lys(Z
)−OH17,8g、DMF50mlを加えWSe2.
3gを滴下する。2時間後、室温に戻し24時間攪拌す
る。反応液に酢酸エチル1.200m1と水500m1
を加え分液する。上層を水、5%炭酸水素ナトリウム水
、5%クエン酸水、飽和食塩水の順に洗浄し、溶媒を留
去し、得られた残渣にエーテル2oom1、石油x −
テJl/ 400m lを加え結晶化する。結晶を位取
、石油エーテル洗浄し乾燥し、粗結晶を得る。粗結晶を
アセトン200m1に懸濁し40℃にて30分間攪拌し
、エーテル400m lを加えて室温に戻し濾取、乾燥
して化合物11を得る。
Yield 22.0g <93.6%) Melting point 146-147°C CCr], -54,8° (C=1, MeOH) (3
) Boc-Lys(Z)-Val-Leu-Gl
Production of y-0Pac (Compound 11) 21.5 g of Compound 10 was dissolved in 66.5 ml of TFA, stirred at room temperature for 40 minutes, and then dissolved in 140 ml of THF.
1 and neutralized with 113.3 ml of E ta N under water cooling. Add HOBt 6JgSBoc-Lys (Z
)-OH 17.8g and DMF 50ml were added and WSe2.
Add 3g dropwise. After 2 hours, the mixture was returned to room temperature and stirred for 24 hours. Add 1.200ml of ethyl acetate and 500ml of water to the reaction solution.
Add and separate the liquids. The upper layer was washed with water, 5% aqueous sodium bicarbonate, 5% aqueous citric acid, and saturated saline in this order, the solvent was distilled off, and the resulting residue was mixed with 2 ooml of ether and x -
Add 400 ml of TeJl and crystallize. The crystals are scaled, washed with petroleum ether, and dried to obtain crude crystals. The crude crystals were suspended in 200 ml of acetone, stirred at 40°C for 30 minutes, added with 400 ml of ether, returned to room temperature, collected by filtration, and dried to obtain Compound 11.

収量 27.2g (80,1%) 融点 189〜191℃ 〔α) 、−21,7°(C=1.、DMF)(4,)
  PMZ−Arg(Mts)−Lys(Z)−Val
−Leu −G ly −OPac (化合物12)の
製造化合物115.5gをT F A 11.3mlニ
溶解し、室温で40分攪拌した後、T H−F 24m
1を加え氷冷下E b N 20.2mlで中和する。
Yield 27.2g (80.1%) Melting point 189-191°C [α), -21.7° (C=1., DMF) (4,)
PMZ-Arg(Mts)-Lys(Z)-Val
-Leu -G ly -OPac (Compound 12) 115.5 g of the compound was dissolved in 11.3 ml of TFA, stirred at room temperature for 40 minutes, and then dissolved in 24 ml of T H-F.
1 and neutralized with 20.2 ml of E b N under ice cooling.

この溶液にHOBt 1.1g、PMZ−Arg(Mt
s)−OH4,5g、 DMF 24m1ヲ加えWSC
l、2gを滴下する。2時間後、室温に戻し244時間
攪拌る。反応液を濃縮し水240m lに5℃以下で滴
下し結晶化する。結晶を濾取し、水、エーテルの順に洗
浄し乾燥し粗結晶を得  彫る。粗結晶をMeOH40
m1に懸濁し40℃にて30分間攪拌し濾取、乾燥して
化合物12を得る。
To this solution, 1.1 g of HOBt, PMZ-Arg (Mt
s) Add 4.5 g of -OH and 24 ml of DMF WSC
Drop 2 g of the solution. After 2 hours, the mixture was returned to room temperature and stirred for 244 hours. The reaction solution was concentrated and added dropwise to 240 ml of water at 5°C or below to crystallize. Filter the crystals, wash with water and ether, and dry to obtain coarse crystals. Coarse crystals in MeOH40
ml, stirred at 40°C for 30 minutes, filtered, and dried to obtain Compound 12.

収量 7.1g (84,8%) 融点 200〜203℃ 〔α)、−10,7°(C=1.DMF)(5)  P
MZ−Arg(Mts)−Lys(Z)−Val−Le
u−Gly−OH(化合物13)の製造化合物12 4
.9gをA co 8100m1に溶解し亜鉛粉末7,
5gを少量ずつ10分間隔で加え、3時間匿拌する。セ
ライト濾過し溶媒を留去し、得られた残渣にエーテル1
00m lを加え結晶化する。結晶を濾取、エーテル洗
浄し乾燥して化合物13を得る。
Yield 7.1g (84.8%) Melting point 200-203℃ [α), -10.7° (C=1.DMF) (5) P
MZ-Arg(Mts)-Lys(Z)-Val-Le
Production of u-Gly-OH (compound 13) Compound 12 4
.. Dissolve 9g in A co 8100ml and add zinc powder 7,
Add 5 g in small portions at 10 minute intervals and stir for 3 hours. After filtering through Celite and distilling off the solvent, add 1 ether to the resulting residue.
Add 00ml and crystallize. The crystals are collected by filtration, washed with ether, and dried to obtain Compound 13.

収量 4.4g (99,8%) 融点 195〜201℃ 〔α)o−11,1°(C−1,DMF)飽前例3  
Boc−Ile−Phe−Thr−Asn−Ser−T
yr−OH(化合物15)の製造 (1)   Boc−Ile−Phe−Thr(Bzl
)  −Asn−3et (Bzl) −Tyr (B
zl) −0Bzl (化合物14)の製造 Boc−Phe−Thr(Bzl) −Asn−3et
(Bzl) −Tyr (Bzl) −0Bzl [融
点197〜199℃、[α]?+i、3 °(C=1.
DMF))44.7gをアセトニトリル270m1に懸
濁させ、5℃にてメタンスルホン酸39.4gをアセト
ニトリル138m1に溶かした液を滴下し、室温にて1
時間攪拌する。水冷下、DMF480ml、E taN
 37.3g ヲ滴下後、HOBt6.70g、、Bo
c −T Ie−OH・1/2H2010,82gを加
え、続いてWSe2.7gを滴下し、水冷下30分続い
て室温にて2.5時間攪拌する。
Yield 4.4g (99.8%) Melting point 195-201℃ [α) o-11,1° (C-1, DMF) saturation example 3
Boc-Ile-Phe-Thr-Asn-Ser-T
Production of yr-OH (compound 15) (1) Boc-Ile-Phe-Thr (Bzl
) -Asn-3et (Bzl) -Tyr (B
zl) -0Bzl (Compound 14) Production Boc-Phe-Thr(Bzl) -Asn-3et
(Bzl) -Tyr (Bzl) -0Bzl [Melting point 197-199°C, [α]? +i, 3° (C=1.
44.7 g of DMF) was suspended in 270 ml of acetonitrile, and a solution of 39.4 g of methanesulfonic acid dissolved in 138 ml of acetonitrile was added dropwise at 5°C, and the suspension was suspended at room temperature for 1
Stir for an hour. Under water cooling, DMF480ml, EtaN
After dropping 37.3g, HOBt6.70g, Bo
82 g of c-T Ie-OH.1/2H2010 is added, followed by dropwise addition of 2.7 g of WSe, and the mixture is stirred for 30 minutes under water cooling and then for 2.5 hours at room temperature.

反応終了時、水冷下反応液を水4.81にあけ生じた沈
澱を濾取し、水洗後減圧乾煙し、粗化合物1 50.8
gを得た。ついで粗化合物150.8gをアセトニトリ
ル740m 42に’L4Erさせ、室温にて1時間攪
拌後、濾取し、アセトニトリル洗浄後渥圧乾煙し、化合
物14  45゜4gを得た。
At the end of the reaction, the reaction solution was poured into 4.8 ml of water under water cooling, and the resulting precipitate was collected by filtration, washed with water, and then dried under reduced pressure to obtain crude compound 1 50.8 ml.
I got g. Then, 150.8 g of the crude compound was dissolved in 740 mL of acetonitrile, stirred at room temperature for 1 hour, collected by filtration, washed with acetonitrile, and then dried under pressure to obtain 45.4 g of Compound 14.

収量 45.4g (92%) 融点 210〜211℃ 〔α〕′Lニー2.0°(C=1.1.DMF)(2)
    Boc −丁 1e −¥’he−Thr −
Asn−Ser −Tyr−OH(化合物15)の製造 化合物1,4 40.1gをD M F 1.200m
1、酢酸600m1に溶解し、5%Pd−C40,4g
の存在下常圧、40℃で5時間接触還元する。セライト
を用いた濾過で触媒を除き、濾液を減圧濃縮し油状物を
得た。この油状物にエーテルを加えて結晶化し、濾取し
エーテルで洗浄後乾繰して化合物15を得た。
Yield 45.4g (92%) Melting point 210-211℃ [α]′L knee 2.0° (C=1.1.DMF) (2)
Boc -Ding 1e -\'he-Thr -
Production of Asn-Ser -Tyr-OH (compound 15) 40.1 g of compound 1,4 was DMF 1.200 m
1. Dissolved in 600ml of acetic acid, 5% Pd-C40.4g
Catalytic reduction is carried out at 40° C. for 5 hours at normal pressure in the presence of. The catalyst was removed by filtration through Celite, and the filtrate was concentrated under reduced pressure to obtain an oil. Ether was added to this oil to crystallize it, which was collected by filtration, washed with ether, and dried to obtain Compound 15.

収量 22.7g (80,7%) 融点 199℃(分解) 〔α〕τ+1.9°(C=1.1.DMF)参考例4 
 Boc −Tyr (C12−Bzl)−八1a−A
sp(OBzl) −Ala−OH(化合物19)の製
造 (1)  Boc−Asp(OBzl) −Ala−O
Pac(化合物16)の製造 TosOH−H−Ala−OPac  100g、Bo
c−Asp(OBzl) OH93,7g及びHOBt
 39.2gをDMF750mAに溶解する。WSC4
5,0gを一10℃で1.5時間滴下し同温度で更に一
時間攪拌する。
Yield 22.7g (80.7%) Melting point 199℃ (decomposition) [α]τ+1.9° (C=1.1.DMF) Reference example 4
Boc-Tyr (C12-Bzl)-81a-A
Production of sp(OBzl)-Ala-OH (compound 19) (1) Boc-Asp(OBzl)-Ala-O
Preparation of Pac (compound 16) TosOH-H-Ala-OPac 100g, Bo
c-Asp(OBzl) OH93.7g and HOBt
Dissolve 39.2 g in DMF 750 mA. WSC4
5.0 g was added dropwise at -10°C for 1.5 hours and stirred at the same temperature for an additional hour.

酢酸エチル1β及び飽和食塩水600m lを加え層を
分離する。有機層を5%クエン酸水、8%炭酸水素す)
 IJウム水、水の順に洗浄する。硫酸マグネシウム上
で乾煙し溶媒を留去する。残渣を濾取しヘキサンで洗浄
し化合物16を得る。
Ethyl acetate 1β and 600 ml of saturated saline were added and the layers were separated. The organic layer was dissolved in 5% citric acid water and 8% hydrogen carbonate)
Wash with IJum water and water in that order. Dry smoke over magnesium sulfate and evaporate the solvent. The residue is collected by filtration and washed with hexane to obtain Compound 16.

収ffi  114g <84.4%)融点 107〜
109℃ (α)o  36,7°(C= 1 、MeOH)(2
)  Boc−Ala−Asp(OBzl)  −Al
a −0Pac(化合物17)の製造 化合物16 40.0gをアセトニトリル240m l
に溶解しP−トルエンスルホン酸−水和物59.3gを
加え室温で1時間皿押する。−10℃に冷却下EtaN
 31.5gで中和し脱Boc化物溶液を得る。
Yield 114g <84.4%) Melting point 107~
109°C (α)o 36,7° (C=1, MeOH) (2
) Boc-Ala-Asp(OBzl)-Al
Production of a-0Pac (Compound 17) 40.0 g of Compound 16 was dissolved in 240 ml of acetonitrile.
59.3 g of P-toluenesulfonic acid hydrate was added to the solution, and the mixture was pressed for 1 hour at room temperature. EtaN under cooling to -10℃
Neutralize with 31.5 g to obtain a de-Boc solution.

一方Boc −A Ia −OH16,2gを酢酸エチ
ル80m1に溶解し一1O℃で冷却下NMML66g及
び5BCF 11.8gを5分間で滴下する。同温度で
更に15分間攪拌した後先の脱BOC化物溶液を15分
間滴下し自然昇温させなか、ら3時間攪拌する。酢酸エ
チル600m l及び飽和食塩水300m1を加え層を
分離する。有機層を5%クエン酸水、8%炭酸水素ナト
リウム水、水の順に洗浄する。硫酸マグネシウム上で乾
繰した後溶媒を減圧留去する。残渣を酢酸エチル−ヘキ
サンで再結晶し化合物17を得る。  収量 42.6
g (93,6%)融点 145〜147℃ 〔α)、−51,0° (C=1.DlvlF)(3)
  Boc−Tyr (CI2− Bzl)  −A 
Ia−Asp(OBzl)−Ala−OPac(化合物
18)の製造 化合物1?  20.0 gをアセトニトリルZoom
 1に懸濁する。P−)ルエンスルホン酸−水和物26
.0gを加え室温で1時間攪拌する。−10℃に冷却下
Et3N 13.8gで中和し脱Boc化物溶液を得る
。一方Boa −Tyr (CI2− Bzl) −O
H16,6gをTHF50gに溶解しNMM3.80g
を加える。−10℃に冷却下5BCF5.16gを加え
15分間既皿押る。先の脱Boc化物溶液を15分間滴
下し自然昇温させながら3時間攪拌する。酢酸エチル5
00m l及び飽和食塩水200m lを加え層を分離
する。有機層を8%炭酸水素ナトリウム、水の順に洗浄
する。硫酸マグネシウム上で乾俣する。ヘキサン 50
0m lを加える。析出した沈澱を心数しヘキサン洗浄
して化合物18を得る。
On the other hand, 16.2 g of Boc-A Ia-OH was dissolved in 80 ml of ethyl acetate, and 66 g of NMML and 11.8 g of 5BCF were added dropwise over 5 minutes while cooling at -10°C. After stirring for another 15 minutes at the same temperature, the BOC-removed solution was added dropwise for 15 minutes and the mixture was stirred for 3 hours while allowing the temperature to rise naturally. Add 600 ml of ethyl acetate and 300 ml of saturated brine and separate the layers. The organic layer is washed sequentially with 5% citric acid water, 8% sodium bicarbonate water, and water. After drying over magnesium sulfate, the solvent was distilled off under reduced pressure. The residue was recrystallized from ethyl acetate-hexane to obtain Compound 17. Yield 42.6
g (93,6%) Melting point 145-147°C [α), -51,0° (C=1.DlvlF) (3)
Boc-Tyr (CI2- Bzl) -A
Preparation of Ia-Asp(OBzl)-Ala-OPac (Compound 18) Compound 1? 20.0 g of acetonitrile Zoom
1. P-) Luenesulfonic acid hydrate 26
.. Add 0g and stir at room temperature for 1 hour. The mixture was cooled to −10° C. and neutralized with 13.8 g of Et3N to obtain a Boc-free solution. On the other hand, Boa -Tyr (CI2- Bzl) -O
Dissolve H16.6g in THF50g and NMM3.80g
Add. While cooling to -10°C, add 5.16 g of 5BCF and press the plate for 15 minutes. The above Boc-removed solution was added dropwise for 15 minutes, and the mixture was stirred for 3 hours while allowing the temperature to rise naturally. ethyl acetate 5
00 ml and 200 ml of saturated saline were added and the layers were separated. The organic layer is washed sequentially with 8% sodium bicarbonate and water. Dry over magnesium sulfate. Hexane 50
Add 0ml. Compound 18 is obtained by filtering the precipitate and washing with hexane.

収−25,0g 融点 174〜176℃ 〔α〕覆−20.7°(C=1.DMF)(4)  B
oc−Tyr (CI2− Bzl) −A Ia−A
sp(013zl) −Ala−○H(化合物19)の
製造化合物18 20.0 gを酢酸240m1に溶解
する。
Yield: -25.0g Melting point: 174-176°C [α] -20.7° (C=1.DMF) (4) B
oc-Tyr (CI2- Bzl) -A Ia-A
Preparation of sp(013zl) -Ala-○H (Compound 19) 20.0 g of Compound 18 is dissolved in 240 ml of acetic acid.

亜鉛粉末219 gを加え室温で1時間攪拌する。不溶
物を鑓別した後溶媒を留去する。残渣を水洗し濾取乾燥
する。酢酸エチル−ヘキサンで再結晶して化合物19を
得る。
Add 219 g of zinc powder and stir at room temperature for 1 hour. After removing the insoluble matter, the solvent is distilled off. The residue is washed with water, filtered and dried. Compound 19 is obtained by recrystallization from ethyl acetate-hexane.

収量 14.2g (81,3%) 融点 132〜138℃ 〔α〕π−14,2°(C=1.DMF)実施例I H−Tyr −A la −Asp −A la−I 
Ie −Phe −Thr−Asn−5er−Tyr−
Arg−Lys−Val−Leu −G Iy −G 
In −Leu −Ser −A la −Arg −
Lys −Leu −Leu−G In −Asp −
I le −Met −Ser −Arg −N I2
 (ポリペプチド■)の製造(1)  H−Leu−G
ln−Asp(OBzl)−Ile −Met(0)−
3et(Bzl)−Arg(Mts)−NI2(化合物
20)の製造 Boc−Leu−Gln−Asp(OBzl)  −I
le−Met(○) −Ser (Bzl)−八rg(
Mts)−NI2(融点220〜222℃[α]。−1
0,7゜(C:1、DMSO):15.0gをTFA3
0mlに溶解し室温で1時間攪拌する。水500m l
に予めE t= N 54.2mlを溶解したものを氷
冷し先のTFA溶液を滴下する。析出した沈澱を濾取、
水洗し乾燥して化合物20を得る。
Yield 14.2g (81.3%) Melting point 132-138°C [α]π-14,2° (C=1.DMF) Example I H-Tyr -A la -Asp -A la-I
Ie -Phe -Thr-Asn-5er-Tyr-
Arg-Lys-Val-Leu-G Iy-G
In -Leu -Ser -A la -Arg -
Lys -Leu -Leu-G In -Asp -
I le -Met -Ser -Arg -N I2
Production of (polypeptide ■) (1) H-Leu-G
ln-Asp(OBzl)-Ile-Met(0)-
Preparation of 3et(Bzl)-Arg(Mts)-NI2 (Compound 20) Boc-Leu-Gln-Asp(OBzl)-I
le-Met(○) -Ser (Bzl)-8rg(
Mts)-NI2 (melting point 220-222°C [α].-1
0.7° (C:1, DMSO): 15.0g of TFA3
Dissolve in 0 ml and stir at room temperature for 1 hour. 500ml water
54.2 ml of E t=N was previously dissolved in the solution, cooled on ice, and the TFA solution was added dropwise. Collect the precipitate by filtration,
Compound 20 is obtained by washing with water and drying.

収量 4.55g (98,3%) 融点 203〜210℃ 〔α〕〒−7.0°(C=1.DMSO)(2)  B
oc−Gln−Leu−8,er(Bzl) −Ala
−Arg(Mts)−Lys(Z)−Leu−Leu−
Gln−Asp(OBzl)−Ile−Met(0)−
Ser (Bzl) −Arg (Mts) −N I
2 (化合物21)の製造 化合物8 2,60.g、化合物202.54g及びH
OS u 272mgをDMF5ml DMSO2,5
mlの混合溶媒に溶解する。DCCA36mgを加える
。NMMを加えて弱アルカリ性(pH7〜8)に保ちな
がら室温で24時間攪拌する。水50m1に反応混合物
を滴下する。析出した沈澱を濾取しMeOH30m1に
懸濁し50℃で30分間攪拌する。濾取、乾燥して化合
物21を得る。
Yield 4.55g (98.3%) Melting point 203-210℃ [α] -7.0° (C=1.DMSO) (2) B
oc-Gln-Leu-8,er(Bzl)-Ala
-Arg(Mts)-Lys(Z)-Leu-Leu-
Gln-Asp(OBzl)-Ile-Met(0)-
Ser (Bzl) -Arg (Mts) -N I
2 (Compound 21) Production Compound 8 2,60. g, compound 202.54 g and H
OS u 272mg DMF5ml DMSO2,5
ml of mixed solvent. Add 36 mg of DCCA. Add NMM and stir at room temperature for 24 hours while keeping the mixture slightly alkaline (pH 7-8). The reaction mixture is added dropwise to 50 ml of water. The deposited precipitate was collected by filtration, suspended in 30 ml of MeOH, and stirred at 50°C for 30 minutes. Compound 21 is obtained by filtering and drying.

収量 4.16g (816%) 融点 270〜271℃ 〔α〕τ−17.2°(C=1.DMSO)(3)  
 H−Gln−Leu−Ser(Bzl)  −Ala
−Arg(Mts) −Lys(Z) −Leu−Le
u −Gln−Asp(OBzl) −I le −M
et (0)−Ser(Bzl) −Arg(Mts)
 −NI2(化合物22)の製造 化合物2j 3.50gをTFA35mlに溶解し水冷
下30分造拌する。水500m lに予めEtaN66
+n Iを溶解したものを氷冷し先のTFA溶液を滴下
する。析出した沈澱を總取し水洗洟乾迩して化合物22
を得る。
Yield 4.16g (816%) Melting point 270-271℃ [α]τ-17.2° (C=1.DMSO) (3)
H-Gln-Leu-Ser(Bzl)-Ala
-Arg(Mts) -Lys(Z) -Leu-Le
u -Gln-Asp(OBzl) -I le -M
et (0)-Ser(Bzl)-Arg(Mts)
-Production of NI2 (Compound 22) 3.50 g of Compound 2j was dissolved in 35 ml of TFA and stirred for 30 minutes under water cooling. Add EtaN66 to 500ml of water in advance.
The +n I solution is cooled on ice, and the TFA solution is added dropwise. The precipitate was collected, washed with water, and dried to obtain compound 22.
get.

収量 3.31.g (98,2%) 融点 264〜267℃ 〔α]?  219° (C=1、DMSO)(4) 
 PMZ−Arg(Mts)−Lys(Z)−Val−
Leu −Gly −Gln −Leu −Ser (
Bzl) −Δla−Arg(Mts)−Lys(Z)
−Leu−Leu−Gln−Asp(OBzl) −I
le−Met(0)−Ser(Bzl)−Arg(Mt
s)−NI2(化合物23)の製造 化合物13 1.87g及びHOB t 325mgを
DMSO20ml及びDMFlomlの混合溶媒に溶解
する。D CC372mg及び化合物22 3.0gを
加える。NMMで弱アルカリ性(pH7〜8) に保ち
ながら室温で10時間攪拌する。
Yield 3.31. g (98,2%) Melting point 264-267℃ [α]? 219° (C=1, DMSO) (4)
PMZ-Arg(Mts)-Lys(Z)-Val-
Leu -Gly -Gln -Leu -Ser (
Bzl) -Δla-Arg(Mts)-Lys(Z)
-Leu-Leu-Gln-Asp(OBzl) -I
le-Met(0)-Ser(Bzl)-Arg(Mt
s) Preparation of -NI2 (Compound 23) 1.87 g of Compound 13 and 325 mg of HOB t are dissolved in a mixed solvent of 20 ml of DMSO and DMFloml. Add 372 mg of D CC and 3.0 g of Compound 22. Stir at room temperature for 10 hours while keeping the mixture slightly alkaline (pH 7-8) with NMM.

水30m1に反応混合物を滴下し析出した沈澱を濾取す
る。MeOH30m1に!I!11濁し50℃で30分
間攪拌する。濾取、乾燥して化合物23を得る。
The reaction mixture was added dropwise to 30 ml of water, and the precipitate was collected by filtration. MeOH30m1! I! 11. Stir at 50°C for 30 minutes. Compound 23 is obtained by filtering and drying.

収量 3.87g (91,5%) 融点 275〜278℃ [α〕2D  19.9°(C=1.DM、5O)(5
)  H−Arg(Mts) −Lys(Z) −Va
t −Lau−Gly−Gln−Leu−Ser(Bz
l) −ΔIa−Arg(Mts)−Lys(Z)−L
eu−Leu−Gln−Asp(OBzl) −Ile
−Met(○) −Ser(Bzl) −Arg(Mt
s) −NH2(化合物24)の製造 化合物23 3.50gをTFA15ml及びアニソー
ル5mlに溶解し水冷下30分攪拌する。水300m1
に予めE ts N 2B、 4mlを溶解したものを
氷冷し先のTFA溶液を滴下する。析出した沈澱を濾取
しMeOHで洗浄後濾取、乾繰して化合物24を得る。
Yield 3.87g (91.5%) Melting point 275-278℃ [α]2D 19.9° (C=1.DM, 5O) (5
) H-Arg(Mts)-Lys(Z)-Va
t -Lau-Gly-Gln-Leu-Ser(Bz
l) -ΔIa-Arg(Mts)-Lys(Z)-L
eu-Leu-Gln-Asp(OBzl)-Ile
-Met(○) -Ser(Bzl) -Arg(Mt
s) Production of -NH2 (Compound 24) 3.50 g of Compound 23 was dissolved in 15 ml of TFA and 5 ml of anisole and stirred for 30 minutes under water cooling. water 300m1
Dissolve 4 ml of EtsN2B in advance, cool on ice, and add the TFA solution dropwise. The deposited precipitate was collected by filtration, washed with MeOH, filtered, and dried to obtain Compound 24.

収量 3.03g (89,1%) 融点 280〜283℃ 〔α)?−2s、o° (C=1.DMSO)(+3)
   Boc −Ile −Phe −Thr −As
n −Ser −Tyr−Arg(Mts) −Lys
(Z)−Val−1、eu−Gly−Gln −Leu
 −Ser (Bzl) −Ala −Arg (Mt
s) −Lys (Z ) −Leu −Leu−Gl
n−Asp (OBzl) −I Ie −Met(0
) −Set (Bzl) −Arg (Mts) −
NH,(化合物25)の製造 化合物24 735mg  化合物15 281mg。
Yield 3.03g (89.1%) Melting point 280-283℃ [α)? -2s, o° (C=1.DMSO) (+3)
Boc-Ile-Phe-Thr-As
n-Ser-Tyr-Arg(Mts)-Lys
(Z)-Val-1, eu-Gly-Gln-Leu
-Ser (Bzl) -Ala -Arg (Mt
s) -Lys (Z) -Leu -Leu-Gl
n-Asp (OBzl) -I Ie -Met(0
) -Set (Bzl) -Arg (Mts) -
Preparation of NH, (Compound 25) Compound 24 735 mg Compound 15 281 mg.

HOBt−一水和物92mgをDMSO7,5ml、N
−メチルピロリドン7.5mlに溶かし、水冷下WSC
塩酸塩70mgを加え、水冷下244時間攪拌た。反応
終了後、反応液に水150m1を加え、30分攪拌後析
出した沈澱を濾取し、水で洗浄後減圧乾煙し、化合物2
5を得た。
92 mg of HOBt-monohydrate was dissolved in 7.5 ml of DMSO, N
-Dissolved in 7.5 ml of methylpyrrolidone and subjected to WSC under water cooling.
70 mg of hydrochloride was added and stirred for 244 hours under water cooling. After the reaction was completed, 150 ml of water was added to the reaction solution, and after stirring for 30 minutes, the deposited precipitate was collected by filtration, washed with water, and dried under reduced pressure to obtain compound 2.
Got 5.

収量 769mg (83,8%) 融点 128〜140℃ 〔α〕、 −11,5° (C=1.L DMSO’)
(7)  Boc−Tyr(c12−Bzl)  −A
la−Asp(OBzl)  −A Ia −I Ie
 −Phe −Thr−Δsn−Ser −Tyr −
Arg、(Mts) −Lys (Z ) −Val−
Leu −G Iy−G In −Leu−Ser (
Bzl)−Ala−Arg(Mts)−Lys(Z)−
Leu−Leu−Gln−Asp(OBzl)−Ile
−Met(0)−3et(Bzl)−Arg(Mts)
−NH2(化合物26)の製造 化合物25 910mgに水冷下T F A 3.39
m1を加え、水冷下1時間攪拌する。続いて食塩−氷冷
却下DMF 3!9ml、 Et、N 7,36m1を
滴下し、さらに水24m lを加え、15分攪拌する。
Yield 769mg (83.8%) Melting point 128-140℃ [α], -11.5° (C=1.L DMSO')
(7) Boc-Tyr(c12-Bzl)-A
la-Asp(OBzl) -A Ia -I Ie
-Phe -Thr-Δsn-Ser -Tyr -
Arg, (Mts) -Lys (Z) -Val-
Leu -G Iy-G In -Leu-Ser (
Bzl)-Ala-Arg(Mts)-Lys(Z)-
Leu-Leu-Gln-Asp(OBzl)-Ile
-Met(0)-3et(Bzl)-Arg(Mts)
-Production of NH2 (Compound 26) 910 mg of Compound 25 was cooled with TFA 3.39
Add m1 and stir for 1 hour under water cooling. Subsequently, 3.9 ml of DMF, 7.36 ml of Et, and N were added dropwise to the mixture under ice-cooling with sodium chloride, followed by addition of 24 ml of water, and the mixture was stirred for 15 minutes.

析出した沈澱を濾取し、水で洗浄後、減圧乾慢し、化合
物25の脱Boc体910mgを得た。
The deposited precipitate was collected by filtration, washed with water, and dried under reduced pressure to obtain 910 mg of Compound 25 without Boc.

上記の処理により得た化合物25の脱Boc体910m
g、化合物19 173mg1HOBt・−水和物67
mgをDMSO4,5ml、N−メチルピロリドン4.
5mlに溶かし、氷冷下WSC・塩酸塩46mgを加え
、水冷下30分、続いて室温で2時間攪拌した。反応終
了後、反応液に水90m1を加え、析出した沈澱を濾取
し、水で洗浄後、減圧乾煙し、化合物26を得た。
910m of de-Boc compound of compound 25 obtained by the above treatment
g, Compound 19 173mg1HOBt・-hydrate 67
4.mg of DMSO, 5ml of N-methylpyrrolidone.
The mixture was dissolved in 5 ml, and 46 mg of WSC/hydrochloride was added under ice-cooling, followed by stirring for 30 minutes under water-cooling and then at room temperature for 2 hours. After the reaction was completed, 90 ml of water was added to the reaction solution, and the precipitate precipitated was collected by filtration, washed with water, and then dried under reduced pressure to obtain Compound 26.

収ffi  936mg (88,5%)融点 130
〜145℃ 〔α〕。−10,8°(、C=1.0.DMSO)(8
)ポリペプチド(VI)の製造 化合物26 300+y+gにm−クレゾール287μ
β、チオアニソール323μ!トリクロロメチルシラン
302μA、 TFA 1.8ml、  トリフルオロ
メタンスルホン酸304μβを加え、氷冷下2゜5時間
攪拌した。反応液をエーテル50m1に加え、析出した
沈澱を置数し、エーテルで洗浄した。得られtこ沈澱物
を5%酢酸水90m1.2−メルカプトエタノール9m
lに溶かし、水酸化すl−Uラム水でpH9にし、1時
間攪拌後、酢酸にてpH5とした。この溶液を逆相カラ
ムクロマト(YMC−GEL  0DSS −15/3
0 )  20 X 300柵に吸着させ、水、0、I
M  Ac0NH471<(pH5,0)の順で洗浄後
、35%アセトニトリル−65%0.1!、I  Ac
○NH,水(pH5,0)で溶出させた。600m1〜
650m1溶出画分を集め濃縮した。この濃縮液を、再
び逆相カラムクロマ)(YMC−GE L  OD S
  S −15/30) 20X300mmに吸着させ
、1%酢酸水で洗浄後、22%アセトニトリル−78%
 1%酢酸水で溶出させた。700m1〜800m1の
溶出画分を集め、減圧濃縮後、凍結乾煙することにより
目的とするポリペプチド(VI)56mgを得た。
Yield: 936mg (88.5%) Melting point: 130
~145℃ [α]. −10,8°(, C=1.0.DMSO)(8
) Production of polypeptide (VI) Compound 26 300+y+g and m-cresol 287μ
β, thioanisole 323μ! 302 μA of trichloromethylsilane, 1.8 ml of TFA, and 304 μβ of trifluoromethanesulfonic acid were added, and the mixture was stirred for 2.5 hours under ice cooling. The reaction solution was added to 50 ml of ether, and the precipitate was placed and washed with ether. The obtained precipitate was dissolved in 90 ml of 5% acetic acid and 9 ml of 1.2-mercaptoethanol.
The mixture was dissolved in 1 ml of hydroxide, adjusted to pH 9 with 1-U hydroxide rum water, stirred for 1 hour, and adjusted to pH 5 with acetic acid. This solution was subjected to reverse phase column chromatography (YMC-GEL 0DSS-15/3
0) Adsorbed on 20 x 300 fence, water, 0, I
After washing in the order of M Ac0NH471<(pH5,0), 35% acetonitrile-65%0.1! ,I Ac
Eluted with NH and water (pH 5, 0). 600m1~
A 650ml elution fraction was collected and concentrated. This concentrated solution was again subjected to reverse phase column chroma) (YMC-GE LOD S
S-15/30) Adsorbed on 20x300mm, washed with 1% acetic acid water, then 22% acetonitrile-78%
Elution was performed with 1% acetic acid water. Elution fractions of 700 ml to 800 ml were collected, concentrated under reduced pressure, and freeze-dried to obtain 56 mg of the target polypeptide (VI).

[:α〕、−65°(C=0.1. H2O)実施例1
により得られた化合物2526及びポリペプチド(VI
)のアミノ酸分析値を第1第1表 ・ 分析値は、6規定塩酸加水分解によるものである。
[:α], -65° (C=0.1.H2O) Example 1
Compound 2526 and polypeptide (VI
) Amino acid analysis values are shown in Table 1. Analysis values are based on 6N hydrochloric acid hydrolysis.

・ カッコ内は理論値・Theoretical values are in parentheses

Claims (2)

【特許請求の範囲】[Claims] (1)保護基を有するペプチドフラグメント( I )と
保護基を有するペプチドフラグメント(II)を縮合させ
、縮合物を得、次いでこの縮合物と保護基を有するペプ
チドフラグメント(III)とを縮合させる。以下順次保
護基を有するペプチドフラグメント(IV)、(V)を縮
合させた後、脱保護することを特徴とする次のアミノ酸
配列を有するポリペプチド(VI)の製法。 【アミノ酸配列があります】(VI) ただし、ペプチドフラグメント( I )〜 (V)は次の式で表わされる。 ペプチドフラグメント( I ) Leu−Gln−Asp−Ile−Met−Ser−A
rg−NH_2 ペプチドフラグメント(II) Gln−Leu−Ser−Ala−Arg−Lys−L
eu ペプチドフラグメント(III) Arg−Lys−Val−Leu−Gly ペプチドフラグメント(IV) Ile−Phe−Thr−Asn−Ser−Tyrペプ
チドフラグメント(V) Tyr−Ala−Asp−Ala (式中グリシンをのぞくすべてのアミノ酸はL−体を表
す。)
(1) A peptide fragment (I) having a protecting group is condensed with a peptide fragment (II) having a protecting group to obtain a condensate, and then this condensate is condensed with a peptide fragment (III) having a protecting group. A method for producing a polypeptide (VI) having the following amino acid sequence, which comprises sequentially condensing peptide fragments (IV) and (V) having protecting groups and then deprotecting them. [There is an amino acid sequence] (VI) However, the peptide fragments (I) to (V) are represented by the following formula. Peptide fragment (I) Leu-Gln-Asp-Ile-Met-Ser-A
rg-NH_2 Peptide fragment (II) Gln-Leu-Ser-Ala-Arg-Lys-L
eu Peptide fragment (III) Arg-Lys-Val-Leu-Gly Peptide fragment (IV) Ile-Phe-Thr-Asn-Ser-Tyr peptide fragment (V) Tyr-Ala-Asp-Ala (all except glycine in the formula The amino acids in represent the L-form.)
(2)保護基を有するペプチドフラグメント(II)、(
III)、(IV)および(V)の縮合法と してカルボジイミド型縮合剤+添加物法を 用いる特許請求の範囲第1項記載のポリペ プチド(VI)の製法。
(2) Peptide fragment (II) with a protecting group, (
The method for producing polypeptide (VI) according to claim 1, which uses a carbodiimide condensing agent + additive method as the condensation method for III), (IV) and (V).
JP60279682A 1985-03-06 1985-12-11 Production of polypeptide Pending JPS62138500A (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP60279682A JPS62138500A (en) 1985-12-11 1985-12-11 Production of polypeptide
EP86102737A EP0193910A3 (en) 1985-03-06 1986-03-03 Synthesis of a derivative of grf and intermediate peptides
KR1019860001580A KR920006564B1 (en) 1985-03-06 1986-03-06 Process for preparing grf derivatives
US07/119,279 US4774319A (en) 1985-03-06 1987-11-09 Synthesis of a derivative of GRF and intermediate peptides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60279682A JPS62138500A (en) 1985-12-11 1985-12-11 Production of polypeptide

Publications (1)

Publication Number Publication Date
JPS62138500A true JPS62138500A (en) 1987-06-22

Family

ID=17614399

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60279682A Pending JPS62138500A (en) 1985-03-06 1985-12-11 Production of polypeptide

Country Status (1)

Country Link
JP (1) JPS62138500A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003511420A (en) * 1999-10-13 2003-03-25 カイロン コーポレイション Methods for obtaining a cellular immune response from proteins
JP2005060314A (en) * 2003-08-13 2005-03-10 Masao Tanihara Cosmetic

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003511420A (en) * 1999-10-13 2003-03-25 カイロン コーポレイション Methods for obtaining a cellular immune response from proteins
JP2005060314A (en) * 2003-08-13 2005-03-10 Masao Tanihara Cosmetic

Similar Documents

Publication Publication Date Title
NO140854B (en) ANALOGICAL PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE NONAPEPTIDE AMIDES
JPH085916B2 (en) New calcitonin derivative
US4490364A (en) CCK Agonists II
KR100251496B1 (en) Hexapeptide
US5324833A (en) Protected amino acids and process for the preparation thereof
EP0292729B1 (en) Process for solid phase peptide synthesis
JPS62228100A (en) Peptide having sulfuric acid ester
CH636598A5 (en) METHOD FOR PRODUCING NEW PSYCHOPHARMACOLOGICALLY ACTIVE PEPTIDES.
US3749703A (en) Asn15-bovine thyrocalcitonin
FR2557114A1 (en) NOVEL DERIVATIVES OF GONADOLIBERIN, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
WAKIMASU et al. 4-Methoxy-2, 3, 6-trimethylbenzenesulfonyl (Mtr): a new amino and imidazole protecting group in peptide synthesis
CA1253299A (en) Polypeptide and process for producing the same
JPS62138500A (en) Production of polypeptide
SU1531857A3 (en) Method of obtaining peptides
JPH09503200A (en) Oligopeptide derived from C-reactive protein fragment
US4530836A (en) Peptide
JPH0223543B2 (en)
EP0360481B1 (en) New pentapeptide and a process for the preparation thereof
CA1131217A (en) Psycho-pharmacological peptides
EP0217804A1 (en) Analogs of substances p.
RU2073010C1 (en) Method of synthesis of lysine-vasopressin in solution
KR100272310B1 (en) A method for preparation over 1-deamino-8-d-arginine vasopressin acetate
US4407745A (en) Heptacosapeptide
JPS6299A (en) Production of polypeptide
JPH08333389A (en) Production of hexapeptide